Diamyd Medical AB (publ) reported earnings results for the second quarter and six months ended February 29, 2024. For the second quarter, the company reported sales was SEK 0.026 million compared to SEK 0.113 million a year ago. Revenue was SEK 1.16 million compared to SEK 1.64 million a year ago. Net loss was SEK 29.25 million compared to SEK 24.97 million a year ago. Basic loss per share from continuing operations was SEK 0.3 compared to SEK 0.3 a year ago.
For the six months, sales was SEK 0.06 million compared to SEK 0.324 million a year ago. Revenue was SEK 2.15 million compared to SEK 2.61 million a year ago. Net loss was SEK 62.04 million compared to SEK 57.93 million a year ago. Basic loss per share from continuing operations was SEK 0.7 compared to SEK 0.8 a year ago.